Claims
- 1. A method of treating breast carcinoma in a human in need of such treatment comprising the steps of administering to said human, in a systemic, in vitro manner, an anti-tumor effective amount of a compound selected from the group consisting of4-(4-Ethoxy-phenyl)-2-(N′-fluoren-9-ylidene-hydrazino)-2-hydroxy-4-oxo-butyric acid methyl ester; 2-{N′-[1-(4-Chloro-phenyl)-ethylidene]-hydrazino}-4-oxo-4-phenyl-but-2-enoic acid methyl ester; 4-Chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester; and 2-(N′-Fluoren-9-ylidene-hydrazino)-4-oxo-4-phenyl-but-2-enoic acid methyl ester having the common property of anti-tumor activity against human breast cancer.
Parent Case Info
This application is a divisional of Ser. No. 10/164,541 filed Jun. 7, 2002, now U.S. Pat. No. 6,602,907, which claims benefit of Ser. No. 60/296,823 filed on Jun. 8, 2001.
Non-Patent Literature Citations (2)
Entry |
Konyukhova et al., 2002, CAS:136:325478.* |
Andrejchikov et al., 1995, CAS:123:227828. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/296823 |
Jun 2001 |
US |